Endocrine Disruptors and Polycystic Ovary Syndrome: Phthalates

AKIN L., KENDİRCİ M., NARİN F., KURTOĞLU S., HATİPOĞLU N., ELMALI F.

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, cilt.12, sa.4, ss.393-400, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.4274/jcrpe.galenos.2020.2020.0037
  • Dergi Adı: JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.393-400
  • Anahtar Kelimeler: Phthalate, di-(2-ethylhexyl)-phthalate, mono-(2-ethylhexyl)-phthalate, endocrine disrupter, polycystic ovary syndrome, MONO-(2-ETHYLHEXYL) PHTHALATE, DI-(2-ETHYLHEXYL) PHTHALATE, INSULIN-RESISTANCE, BISPHENOL-A, TOXICITY, STEROIDOGENESIS, DIAGNOSIS, EXPOSURE, CHILDREN, CELLS
  • Erciyes Üniversitesi Adresli: Evet

Özet

Objective: We aimed to investigate a possible role of the endocrine disruptors phthalates, di-2-ethylhexyl phthalate (DEHP) and mono (2-ethylhexyl) phthalate (MEHP), in polycystic ovary syndrome (PCOS) aetiopathogenesis. We also wished to evaluate the relationship between phthalates and metabolic disturbances in adolescents with PCOS.